CIK 0001601485
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113430072
- Phone
- +1 857-209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Venkatesan Jay bought 277,244 shares at an average $2.63 ($730,373)
- 4 Open-market buy Venkatesan Jay bought 3,527 shares at $2.54 ($8,976)
- 4 Open-market sale Neylan John F. sold 358 shares at $2.62 ($938)
- 4 Open-market buy Venkatesan Jay bought 41,625 shares at an average $2.55 ($105,951)
- 4 Open-market buy Venkatesan Jay bought 77,604 shares at $2.41 ($186,956)
- 4 Open-market buy CURHAN GREGORY S bought 4,000 shares at $2.37 ($9,480)
- 4 Open-market sale Rhodes Jennifer J sold 451 shares at $2.42 ($1,090)
- 4 Open-market sale Goldberg Itzhak sold 32,118 shares at $3.35 ($107,721)
- 4 Open-market sale Goldberg Itzhak sold 117,882 shares at an average $3.48 ($410,211)
- 4 Open-market sale Neylan John F. sold 374 shares at $4.13 ($1,545)
- 4 Open-market sale Goldberg Itzhak sold 150,000 shares at an average $4.19 ($629,051)
- 4 Open-market sale Rhodes Jennifer J sold 433 shares at $4.40 ($1,905)
- 4 Open-market sale Neylan John F. sold 373 shares at $8.62 ($3,215)
- 4 Open-market sale Rhodes Jennifer J sold 430 shares at $8.65 ($3,720)
- 4 Open-market sale Neylan John F. sold 376 shares at $10.07 ($3,786)
- 4 Open-market sale Rhodes Jennifer J sold 430 shares at $10.64 ($4,575)
Page 5 of 7 · 140 filings